MAGI3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.703000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.550000E-01
Normal-vs-Stage2
9.914000E-01
Normal-vs-Stage3
5.821000E-01
Normal-vs-Stage4
3.043600E-01
Stage1-vs-Stage2
9.048600E-01
Stage1-vs-Stage3
3.606400E-01
Stage1-vs-Stage4
2.483400E-01
Stage2-vs-Stage3
2.862800E-01
Stage2-vs-Stage4
3.250200E-02
Stage3-vs-Stage4
3.663700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.104400E-01
Normal-vs-AfricanAmerican
7.049400E-01
Normal-vs-Asian
8.038600E-01
Caucasian-vs-AfricanAmerican
3.163600E-01
Caucasian-vs-Asian
3.755000E-01
AfricanAmerican-vs-Asian
8.333600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.527600E-01
Normal-vs-Female
9.269600E-01
Male-vs-Female
3.017800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.304600E-01
Normal-vs-Age(41-60Yrs)
8.235800E-01
Normal-vs-Age(61-80Yrs)
8.879200E-01
Normal-vs-Age(81-100Yrs)
6.304200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.274600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.781200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.193800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.696190E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.820600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.962400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.564800E-01
Normal-vs-Daily Drinker
7.433200E-01
Normal-vs-Weekly Drinker
4.925000E-01
Normal-vs-Occasional Drinker
6.620400E-01
Normal-vs-Social Drinker
8.104800E-01
Non Drinker-vs-Daily Drinker
6.599400E-01
Non Drinker-vs-Weekly Drinker
3.309800E-01
Non Drinker-vs-Occasional Drinker
1.766230E-01
Non Drinker-vs-Social Drinker
8.597600E-01
Daily Drinker-vs-Weekly Drinker
6.550600E-01
Daily Drinker-vs-Occasional Drinker
1.341240E-01
Daily Drinker-vs-Social Drinker
8.385400E-01
Weekly Drinker-vs-Occasional Drinker
4.504400E-02
Weekly Drinker-vs-Social Drinker
4.955200E-01
Occasional Drinker-vs-Social Drinker
2.073800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.532000E-02
Normal-vs-Grade 2
6.144800E-03
Normal-vs-Grade 3
2.636900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.593700E-02
Grade 1-vs-Grade 3
2.465400E-01
Grade 1-vs-Grade 4
5.532000E-02
Grade 2-vs-Grade 3
2.844800E-01
Grade 2-vs-Grade 4
6.144800E-03
Grade 3-vs-Grade 4
2.636900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.560800E-01
Normal-vs-NonDiabetic
9.472000E-01
Diabetic-vs-NonDiabetic
2.669400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.661000E-01
Normal-vs-NoPancreatitis
7.958400E-01
Pancreatitis-vs-NoPancreatitis
8.438000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.447400E-01
Normal-vs-N1
9.338600E-01
N0-vs-N1
3.111400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.437000E-01
Normal-vs-TP53-NonMutant
7.663000E-01
TP53-Mutant-vs-TP53-NonMutant
1.118240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
